NASDAQ:ZGNX Zogenix, Inc
The recent plummet was due to less than stellar Phase 3 results. With a March 25 PDUFA target on the horizon, longs may have given up and cut their losses. Technical indicate a big gap to fill in the $11-$14 area from October last year. Short.